CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
4 research outputs found
Phase 1/2 study of combination therapy with pexidartinib and sirolimus to target tumor-associated macrophages in malignant peripheral nerve sheath tumors.
Author
Brian Andrew Van Tine
Edward Bentlyewski
+7 more
Gary K. Schwartz
Gulam Abbas Manji
Khanh Tu Do
Nanette Matos
Parag Patwardhan
Shing Mirn Lee
Suzanne George
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
MORPHEUS: A phase Ib/II trial platform evaluating the safety and efficacy of multiple cancer immunotherapy (CIT) combinations in patients (pts) with gastric or pancreatic cancer.
Author
Antoine Hollebecque
Antonia Kwan
+17 more
Do-Youn Oh
Edward Cha
Eileen Mary O'Reilly
Gulam Abbas Manji
Harry H. Yoon
Hila Barak
Hyun Cheol Chung
Jill Lacy
Jun Wang
Kyu-Pyo Kim
Osama E. Rahma
Pakeeza Zahra Sayyed
Salah-Eddin Al-Batran
Syma Iqbal
Tanios S. Bekaii-Saab
Xian He
Xiaosong Zhang
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224):a non-randomised, open-label phase 2 trial
Author
Abby B Siegel
Alan Weiss
+57 more
Allen Cohn
Andrea L Webber
Andreas Kaubisch
Andrew S. Paulson
Andrew X Zhu
Angela Alistar
Ann-Lii Cheng
Arndt Vogel
Atisha Manhas
Benjamin Parsons
Bruno Daniele
Carmine Pinto
Chris Verslype
Daneng Li
Daniel Palmer
David P Cosgrove
Debashis Sarker
Gina Vaccaro
Gontran Verset
Gulam Abbas Manji
Hans Van Vlierberghe
Ivan Borbath
James Lee
Jamil Asselah
Jean-Frederic Blanc
Jena-Luc Van Laethem
Jennifer Knox
Joerg Trojan
Julien Edeline
Junshui Ma
Karl-Heinz Weiss
Kazushi Numata
Ki Chung
Laetitia Fartoux
Magnus Rizell
Mark Karwal
Masatoshi Kudo
Mukul Gupta
Nevena Damjanov
Olivier Rosmorduc
Per I Stal
Richard S Finn
Robert Ramirez
Robin Kelley
Sadahisa Ogasawara
Scot W Ebbinghaus
Simone Strasser
Stephane Cattan
Stephen L Chan
Suresh Ratnam
Tatsuya Yamashita
Timothy Cannon
Timothy Larson
Vittorina Zagonel
Yoshivasu Karino
Yutaka Sasaki
Yvonne Sada
Publication venue
'Elsevier BV'
Publication date
01/07/2018
Field of study
No full text
Crossref
King's Research Portal
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Author
Abby B Siegel
Abou-Alfa
+85 more
Alan Weiss
Allen Cohn
Andrea L Webber
Andreas Kaubisch
Andrew S. Paulson
Andrew X Zhu
Angela Alistar
Ann-Lii Cheng
Arndt Vogel
Atisha Manhas
Benjamin Parsons
Bruix
Bruno Daniele
Carbognin
Carmine Pinto
Cheng
Chris Verslype
Clopper
Daneng Li
Daniel Palmer
David P Cosgrove
Debashis Sarker
Dolled-Filhart
Eisenhauer
El-Khoueiry
Gao
Garon
Gina Vaccaro
Gontran Verset
Gulam Abbas Manji
Hans Van Vlierberghe
Hoshida
Ivan Borbath
James Lee
Jamil Asselah
Jean-Frederic Blanc
Jena-Luc Van Laethem
Jennifer Knox
Joerg Trojan
Julien Edeline
Junshui Ma
Karl-Heinz Weiss
Kazushi Numata
Kelley
Ki Chung
Kudo
Kudo
Laetitia Fartoux
Le
Lencioni
Llovet
Llovet
Magnus Rizell
Mark Karwal
Masatoshi Kudo
Mukul Gupta
Nevena Damjanov
Nishino
Olivier Rosmorduc
Overman
Per I Stal
Prieto
Reck
Richard S Finn
Ringelhan
Robert Ramirez
Robin Kelley
Sadahisa Ogasawara
Sangro
Scot W Ebbinghaus
Sharma
Shi
Simone Strasser
Stephane Cattan
Stephen L Chan
Suresh Ratnam
Tatsuya Yamashita
Timothy Cannon
Timothy Larson
Vittorina Zagonel
Wainberg
Yoshivasu Karino
Yutaka Sasaki
Yvonne Sada
Zheng
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref